The trademark CELERA was filed by Celera Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on August 7, 2000, and received one opposition filed on October 10, 2000 by G.D. Searle LLC on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 10, 2000
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
Two renewals of the trademark were recorded, one on June 16, 2010, and the other one on April 12, 2019.
Change of name and address of the trademark registration was recorded on November 15, 2001. A transfer of the trademark registration was recorded on November 15, 2001. Appointment and Replacement of representative of the trademark registration was recorded on November 16, 2001. Change of name and address of the trademark registration was recorded on June 13, 2002. A transfer of the trademark registration was recorded on June 18, 2007. Change of name and address of the trademark registration was recorded on August 3, 2009. A transfer of the trademark registration was recorded on February 8, 2010. Change of name and professional address of the trademark registration was recorded on July 18, 2012. Appointment and Replacement of representative of the trademark registration was recorded on August 24, 2012. Change of name and professional address of the trademark registration was recorded on September 10, 2021.
The Appeal with reference B R1316/2008-1 was Opposition rejected according to Article 8(1)(b) CTMR with decision issued on October 8, 2009 by the EUIPO. The Opposition with reference B 000314973 was partially refused EUTMA/IR according to Article 8(1)(a) CTMR with decision issued on August 22, 2008 by the EUIPO.
Goods And Services
The mark was filed in class 1 with following description of goods:
Synthetic materials for scientific or medical research use, synthetic DNA, tissues and proteins
Biological materials for scientific or medical research use, tissues, cells and natural DNA
Reagents and other materials for scientific or medical research use.
The mark was filed in class 5 with Medical diagnostic reagents, assays and assay systems and clinical medical reagents, assays and assay systems..
The mark was filed in class 9 with following description of goods:
Computer software and software tools for analysis and management of data and information in the fields of science, technology, medicine, health and their related business, law and public policy areas
Computer software and software tools for analysis and management of genomic databases
Proteonomic databases and disease databases
CD-ROMS, interactive software and computer programs, compact discs, pre-recorded audio and video tapes and cassettes on the subjects of science, technology, medicine, health and their related business, law and public policy areas
CD -ROMS, compact discs and audio and video tapes and cassettes on the subject of science, technology, medicine, health and related business, law and public policy issues
Reports and publications, in electronic format, concerning the subjects of science, technology, medicine, health and related business, law and public policy issues.
The mark was filed in class 42 with following description of goods:
Consultation and research in the fields of science, technology, medicine, health and their related business, law and public policy areas
Providing databases and information in the fields of science, technology, medicine, health and their related business, law and public policy areas
Providing computer service in the fields of science, technology, medicine, health and their related business, law and public policy areas
Providing diagnostic service and assay systems in the fields of medicine and health
Providing biological materials including tissues, cells and natural DNA to the specifications of others
Providing synthetic materials including tissues, proteins and DNA to the specification of others
Developing, producing, distributing and licensing all above products and databases.